» Articles » PMID: 17592248

Deconstructing Pompe Disease by Analyzing Single Muscle Fibers: to See a World in a Grain of Sand

Overview
Journal Autophagy
Specialty Cell Biology
Date 2007 Jun 27
PMID 17592248
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Autophagy is a major pathway for delivery of proteins and organelles to lysosomes where they are degraded and recycled. We have previously shown excessive autophagy in a mouse model of Pompe disease (glycogen storage disease type II), a devastating myopathy caused by a deficiency of the glycogen-degrading lysosomal enzyme acid alpha-glucosidase. The autophagic buildup constituted a major pathological component in skeletal muscle and interfered with delivery of the therapeutic enzyme. To assess the role of autophagy in the pathogenesis of the human disease, we have analyzed vesicles of the lysosomal-degradative pathway in isolated single muscle fibers from Pompe patients. Human myofibers showed abundant autophagosome formation and areas of autophagic buildup of a wide range of sizes. In patients, as in the mouse model, the enormous autophagic buildup causes greater skeletal muscle damage than the enlarged, glycogenfilled lysosomes outside the autophagic regions. Clearing or preventing autophagic buildup seems, therefore, a necessary target of Pompe disease therapy.

Citing Articles

Failure of Autophagy in Pompe Disease.

Do H, Meena N, Raben N Biomolecules. 2024; 14(5).

PMID: 38785980 PMC: 11118179. DOI: 10.3390/biom14050573.


Immunophenotype associated with high sustained antibody titers against enzyme replacement therapy in infantile-onset Pompe disease.

Desai A, Smith P, Yi J, Rosenberg A, Burt T, Kishnani P Front Immunol. 2024; 14:1301912.

PMID: 38250073 PMC: 10798041. DOI: 10.3389/fimmu.2023.1301912.


PRKAA2, MTOR, and TFEB in the regulation of lysosomal damage response and autophagy.

Shariq M, Khan M, Raj R, Ahsan N, Kumar P J Mol Med (Berl). 2024; 102(3):287-311.

PMID: 38183492 DOI: 10.1007/s00109-023-02411-7.


Effects of resistance training on alleviating hypoxia-induced muscle atrophy: Focus on acetylation of FoxO1.

Fu P, Zhu R, Gao W, Gong L J Cell Mol Med. 2023; 28(3):e18096.

PMID: 38149787 PMC: 10844693. DOI: 10.1111/jcmm.18096.


Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening.

Jackson D, Case L, Huggins E, Holland M, Blount J, Webb L Mol Genet Metab Rep. 2023; 36:100989.

PMID: 37670900 PMC: 10475841. DOI: 10.1016/j.ymgmr.2023.100989.